Home Cart Sign in  
Chemical Structure| 210302-17-3 Chemical Structure| 210302-17-3

Structure of BAM 15
CAS No.: 210302-17-3

Chemical Structure| 210302-17-3

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

BAM 15 is an uncoupler of mitochondrial protonophore.

Synonyms: BAM 15

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of BAM 15

CAS No. :210302-17-3
Formula : C16H10F2N6O
M.W : 340.29
SMILES Code : FC1=CC=CC=C1NC2=NC3=NON=C3N=C2NC4=CC=CC=C4F
Synonyms :
BAM 15
MDL No. :MFCD00373912
InChI Key :OEGJBRZAJRPPHL-UHFFFAOYSA-N
Pubchem ID :565708

Safety of BAM 15

GHS Pictogram:
Signal Word:Danger
Hazard Statements:H302-H361-H372-H410
Precautionary Statements:P201-P264-P280-P301+P330+P331-P312
Class:9
UN#:3077
Packing Group:

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
MeWo 10 μM 24 h BAM15 induces mitochondrial fragmentation and inhibits OXPHOS Cell Death Dis. 2018 Jan 18;9(2):29
mouse primary cultured proximal tubule cells (mPPTCs) 1, 2, 5, 10, 20, 50, 100 μM To evaluate the effect of BAM15 on mitochondrial respiratory function in kidney tubule cells. BAM15 acted as a mitochondrial uncoupler, with a concentration-dependent increase in maximal respiration, and 20 μM BAM15 showed superior effects compared to 20 μM FCCP. J Clin Invest. 2023 Apr 3;133(7):e152401
3T3-L1 adipocytes 1 μM acute injection To evaluate the effect of BAM15 on respiratory kinetics in 3T3-L1 adipocytes, results showed responses similar to those observed in C2C12 cells. EMBO Mol Med. 2020 Jul 7;12(7):e12088
AML12 hepatocytes 1 μM acute injection To evaluate the effect of BAM15 on respiratory kinetics in AML12 hepatocytes, results showed responses similar to those observed in C2C12 cells. EMBO Mol Med. 2020 Jul 7;12(7):e12088
SK-Mel28 10 μM 24 h BAM15 induces mitochondrial fragmentation, inhibits OXPHOS, and promotes apoptosis when combined with MAPK signaling inhibition Cell Death Dis. 2018 Jan 18;9(2):29
hiPSC-differentiated retinal tissue 100 μM 5 days To evaluate the protective effect of BAM15 on apoptosis during transportation of retinal tissues, results showed BAM15 reduced the expression of apoptotic marker cleaved caspase3 and increased cell viability Stem Cell Res Ther. 2019 Feb 22;10(1):64
A10 cells 2 µM 5 min Evaluate the effect of BAM15 on AMPK activation, results showed that BAM15 at 2 μmol/L significantly activated AMPK. Acta Pharm Sin B. 2018 Oct;8(6):909-918
A10 cells 10 µM 24 h Evaluate the cytotoxicity of BAM15 on A10 cells, results showed that BAM15 at 10 μmol/L had no significant cytotoxicity. Acta Pharm Sin B. 2018 Oct;8(6):909-918
Mouse Corneal Endothelial Cells (MCEC) 1 μM 24 h BAM15 completely inhibited Gln-induced apoptosis in WT and KO cells. In KO cells exposed to Gln, BAM15 eliminated the excessive mitoROS production, increased the number of polarized mitochondria and reduced the excessive hyperpolarization. Redox Biol. 2019 Sep;26:101260

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
Mice Cecal ligation and puncture (CLP)-induced sepsis model Intraperitoneal injection 5 mg/kg Single dose at 0, 6, or 12 hours post-CLP surgery To assess the impact of BAM15 on sepsis survival and acute kidney injury (AKI). BAM15 significantly increased survival (CLP+vehicle, 25% vs. CLP+BAM15, 75%), improved renal function (reduced serum creatinine and BUN), and reduced kidney tissue damage and oxidative stress. J Clin Invest. 2023 Apr 3;133(7):e152401
C57BL/6J mice Diet-induced obesity model Oral 0.1% w/w BAM15 Daily for 3 weeks To evaluate the effect of BAM15 on body weight, body composition, and glycemic control in diet-induced obese mice, results showed that BAM15 significantly reduced weight gain, improved body composition, and glycemic control. EMBO Mol Med. 2020 Jul 7;12(7):e12088
Mice (C57BL/6J) Diet-induced obesity and insulin resistance model Oral 0.1% w/w (in food) 5 weeks Evaluate the reversal effect of BAM15 on diet-induced obesity and insulin resistance, showing significant reduction in body fat mass, improved insulin sensitivity without affecting food intake or lean mass Nat Commun. 2020 May 14;11(1):2397
Male C57BL/6J mice Aged mice with obesity Oral (via diet) 0.1% w/w (in high fat diet) 10 weeks BAM15 attenuated diet-induced obesity by increasing energy expenditure, improved glucose tolerance, increased muscle mass and function, reduced systemic and muscle inflammation, enhanced mitochondrial quality control and respiratory activity, and decreased ER stress and muscle protein degradation. J Cachexia Sarcopenia Muscle. 2022 Jun;13(3):1821-1836
Drosophila melanogaster Male flies fed a normal diet (ND) or high fat diet (HFD) Dietary supplementation 0.03% BAM15 Throughout the lifespan BAM15 extended life span by ~9% under ND conditions and ~24% under HFD conditions, and improved body composition and locomotor function. Aging Cell. 2024 May;23(5):e14107
Db/db mice Model of severe hyperglycemia, obesity, hypertriglyceridemia, and fatty liver Admixed in diet 0.1% and 0.2% (w/w) 4 weeks To compare the metabolic effects of BAM15 with calorie restriction, results showed high-dose BAM15 (0.2%) outperformed calorie restriction in improving glucose control. Mol Metab. 2023 Mar;69:101684
C57BL/6J mice Diet-induced obese mouse model Dietary admix 0.05% (w/w) Continuous administration for 4 weeks To evaluate the effects of BAM15 combined with semaglutide on body weight, fat mass, glucose tolerance, and liver triglyceride content. Results showed that BAM15 combined with high-dose semaglutide significantly reduced body weight and fat mass, improved glucose tolerance, and decreased liver triglyceride content. Clin Sci (Lond). 2024 Feb 21;138(4):173-187

Clinical Trial:

NCT Number Conditions Phases Recruitment Completion Date Locations
NCT03495895 Family Pregna... More >>ncy, High Risk Less << Not Applicable Recruiting December 2023 Denmark ... More >> VIVE - The Danish Centre of Applied Social Science Recruiting Copenhagen, Denmark, 1052 Contact: Maiken Pontoppidan, ph.d.    +4533697720    mpo@vive.dk    Principal Investigator: Maiken W Pontoppidan, Ph.D Less <<
NCT03659721 At-risk Pregnant Women Not Applicable Not yet recruiting December 31, 2021 Denmark ... More >> VIVE - The Danish Centre of Applied Social Science Copenhagen, Denmark, 1052 Odense University Hospital Not yet recruiting Odense, Denmark, 5000 Contact: Lene Nygaard, Midwife    004540544464    lene.nygaard1@rsyd.dk Less <<
NCT02269787 Enhanced Telephone Monitoring ... More >> Usual Care Less << Not Applicable Active, not recruiting March 30, 2018 United States, California ... More >> VA Palo Alto Health Care System, Palo Alto, CA Palo Alto, California, United States, 94304-1290 Less <<
NCT00887536 Breast Cancer Phase 3 Active, not recruiting January 2022 -

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.94mL

0.59mL

0.29mL

14.69mL

2.94mL

1.47mL

29.39mL

5.88mL

2.94mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
 

Historical Records